Skip to content

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

HyGIeaCare Prep vs Split-dose PEG Prep Prior to Colonoscopy

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02893748
Enrollment
0
Registered
2016-09-08
Start date
2019-03-01
Completion date
2019-03-01
Last updated
2019-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colonoscopy

Keywords

colon, polyps, cancer, screening

Brief summary

The purpose of this study is to compare the level of cleanliness using the HyGIeaCare Prep vs the standard of care Split-dose PEG prep used prior to colonoscopy.

Detailed description

The level of cleanliness will be recorded using the Boston Bowel Prep Score (BBPS) by an endoscopist who is blind to the randomized preparation.

Interventions

Patients will receive the HyGIeaCare Prep, which is an open colon lavage system using warm water by gravity drip to evacuate the colon by stimulating peristalsis to cleanse the colon prior to colonoscopy.

PROCEDUREColonoscopy

Screening colonoscopy as per standard of care.

PEG preparation to be delivered in two doses - 1/2 the night before and 1/2 the morning of the colonoscopy

Sponsors

HyGIeaCare, Inc.
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

1. Patient referred to colonoscopy 2. Patient with high probability for poor prep due to one or more of the following: 1. Chronic constipation (Rome III functional constipation criteria) 2. Gastroparesis 3. Immobilization 4. Diabetes 5. History of poor prep

Exclusion criteria

1. Patient has any condition that, in the opinion of the investigator, may adversely affect the compliance or safety of the patient or would limit the patient's ability to complete the study. 2. Patient is currently taking narcotics. 3. Patient has any of the contraindications listed below: 1. Cardiac: Congestive heart failure (NYHA class III or IV or EF \< 50%) 2. GI: Intestinal perforation, carcinoma of the rectum, fissures or fistula, severe hemorrhoids, abdominal hernia, recent colon or rectal surgery, or abdominal surgery 3. GU: Renal insufficiency (CC \< 60 ml/min/173m2), cirrhosis with ascites 4. Abdominal surgery within the last 6 months 5. Pregnancy

Design outcomes

Primary

MeasureTime frame
Colon cleanliness will be measured in both groups according to the Boston Bowel Preparation Scale (BBPS)Day 1 of colonoscopy

Secondary

MeasureTime frameDescription
Evaluation of patient satisfaction using a Questionnaire2 Days after colonoscopyQuestionnaire
Evaluation of adverse events2 Days after colonoscopyQuestionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026